tiprankstipranks
CIRC Subsidiary Advances Cancer Treatment in China
Company Announcements

CIRC Subsidiary Advances Cancer Treatment in China

China Isotope & Radiation Corp. (HK:1763) has released an update.

Don't Miss our Black Friday Offers:

China Isotope & Radiation Corporation’s subsidiary, CNNC Chengying, has achieved a milestone by obtaining a registration certificate from China’s National Medical Products Administration for its innovative Gamma-ray Stereotactic Radiotherapy System. This advanced medical equipment, powered by domestically-produced cobalt-60, promises to enhance the efficiency and precision of cancer treatments in China. The company anticipates that this achievement will support China’s ‘Healthy China 2030’ initiative and bolster national health security.

For further insights into HK:1763 stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App